Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PRAME family member 9 (PRAMEF9)
- Target
- PRAMEF9
- Molecular classification
- Leucine-rich repeat (LRR) protein, Cancer-testis antigen family (by homology), Other (Unclassified, as specific subclass not clear without functional data)
01
Overview
PRAME family member 9 (PRAMEF9) is a gene encoding a predicted leucine-rich repeat (LRR) protein and a member of the PRAME multigene family, which is mostly characterized by their homologous cancer-testis antigens and roles in transcriptional regulation via retinoic acid receptor (RAR) repression in cancer[1][5]. While PRAME itself is a potent cancer/testis antigen and transcriptional repressor with clinical implications in oncology, there is currently no direct evidence that PRAMEF9 shares these functions or is expressed at comparable levels in tumors or normal tissues. PRAMEF9 has been detected at the transcript level in certain stem, germ, or cancer cells, but its biological function, protein expression, and cellular activity remain uncharacterized[2]. There is no experimental data showing PRAMEF9 interacts with drugs, serves as a disease marker, or constitutes a validated therapeutic target. Its classification and naming are derived from homology and gene family organization rather than validated mechanistic function.
- Other names
- PRAME family member 9PRAMEF9PRAME family member 9/15
02
Mechanism of action
null
03
Biological functions
Other (Unclear/unknown; presumed roles are based on the broader PRAME family and not experimentally confirmed for PRAMEF9)
04
Disease associations
Other (Unclear/uncharacterized; some expression in certain cancer transcriptomes, but not directly linked to any disease pathology)
Beyond the preview
Go deeper on PRAME family member 9 (PRAMEF9).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on PRAME family member 9 (PRAMEF9).